A required review of the US Food and Drug Administration’s communication with industry found that communication was overall timely, collaborative and effective at moving development programs down the road. However, feedback from industry and details of an outside consultant’s report also identified some notable gaps.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,